Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 5
1990 9
1991 14
1992 23
1993 33
1994 32
1995 27
1996 22
1997 20
1998 25
1999 22
2000 27
2001 36
2002 44
2003 29
2004 32
2005 36
2006 34
2007 38
2008 39
2009 33
2010 31
2011 41
2012 40
2013 55
2014 42
2015 45
2016 55
2017 38
2018 39
2019 27
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

914 results
Results by year
Filters applied: . Clear all
Page 1
Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia.
Baron J, Wang ES. Baron J, et al. Expert Rev Clin Pharmacol. 2018 Jun;11(6):549-559. doi: 10.1080/17512433.2018.1478725. Epub 2018 Jun 11. Expert Rev Clin Pharmacol. 2018. PMID: 29787320 Free PMC article. Review.
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.
Kim MY, Yu KR, Kenderian SS, Ruella M, Chen S, Shin TH, Aljanahi AA, Schreeder D, Klichinsky M, Shestova O, Kozlowski MS, Cummins KD, Shan X, Shestov M, Bagg A, Morrissette JJD, Sekhri P, Lazzarotto CR, Calvo KR, Kuhns DB, Donahue RE, Behbehani GK, Tsai SQ, Dunbar CE, Gill S. Kim MY, et al. Cell. 2018 May 31;173(6):1439-1453.e19. doi: 10.1016/j.cell.2018.05.013. Epub 2018 May 31. Cell. 2018. PMID: 29856956 Free PMC article.
Gemtuzumab ozogamicin in acute myeloid leukemia.
Godwin CD, Gale RP, Walter RB. Godwin CD, et al. Leukemia. 2017 Sep;31(9):1855-1868. doi: 10.1038/leu.2017.187. Epub 2017 Jun 13. Leukemia. 2017. PMID: 28607471 Review.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4).
Drgona L, Gudiol C, Lanini S, Salzberger B, Ippolito G, Mikulska M. Drgona L, et al. Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S83-S94. doi: 10.1016/j.cmi.2018.03.022. Epub 2018 Mar 20. Clin Microbiol Infect. 2018. PMID: 29572070 Free article. Review.
Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma.
Santegoets KCM, Gielen PR, Büll C, Schulte BM, Kers-Rebel ED, Küsters B, Bossman SAJFH, Ter Laan M, Wesseling P, Adema GJ. Santegoets KCM, et al. Cancer Immunol Immunother. 2019 Jun;68(6):937-949. doi: 10.1007/s00262-019-02332-w. Epub 2019 Apr 5. Cancer Immunol Immunother. 2019. PMID: 30953118 Free PMC article.
914 results
Jump to page
Feedback